Financhill
Back

ANI Pharmaceuticals Vs. Blueprint Medicines Industry Stock Comparison

Sell
24

ANIP
ANI Pharmaceuticals

Last Price:
$54.36
Seasonality Move:
6.61%
Sell
43

BPMC
Blueprint Medicines

Last Price:
$102.47
Seasonality Move:
5.27%
Sell
24
ANI Pharmaceuticals (ANIP) is a Sell

Is ANI Pharmaceuticals a Buy, Sell or Hold?

  • The current ANI Pharmaceuticals [ANIP] share price is $53.93. The Score for ANIP is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • ANIP is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
43
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy, Sell or Hold?

  • The current Blueprint Medicines [BPMC] share price is $103.36. The Score for BPMC is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • BPMC is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

ANIP Stock Price Chart

What is ANI Pharmaceuticals's stock price today?

  • The ANI Pharmaceuticals share price today is $53.93
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ANIP is experiencing slight buying pressure.

BPMC Stock Price Chart

What is Blueprint Medicines's stock price today?

  • The Blueprint Medicines share price today is $103.36
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BPMC is experiencing buying pressure, which is a positive indicator for future bullish movement.

ANIP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.66 Sell
Relative Strength Index (14 RSI): 42.17 Sell
Chaikin Money Flow: 30282 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.93 - 57.03) Sell
Bollinger Bands (100): (55.46 - 60.54) Sell

BPMC Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.02 Buy
Relative Strength Index (14 RSI): 65.19 Buy
Chaikin Money Flow: 1951173 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (88.25 - 95.81) Buy
Bollinger Bands (100): (87.04 - 95.76) Buy

ANIP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 54.79 Sell
20-day SMA: 54.88 Sell
50-day SMA: 56.69 Sell
200-day SMA: 61.01 Sell
8-day EMA: 54.58 Sell
20-day EMA: 55.13 Sell
50-day EMA: 56.35 Sell
200-day EMA: 58.63 Sell

BPMC Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.01 Buy
20-day SMA: 91.26 Buy
50-day SMA: 93.56 Buy
200-day SMA: 96.81 Buy
8-day EMA: 92.7 Buy
20-day EMA: 91.91 Buy
50-day EMA: 92.32 Buy
200-day EMA: 91.6 Buy

ANI Pharmaceuticals Earnings Growth & ANIP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $1.04 per share.

Blueprint Medicines Earnings Growth & BPMC Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.71 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $2.89 per share.

ANI Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):